25021-246Level 3
Thiotepa (Thiotepa)
**Product type:** Human Prescription Drug
**Active ingredient:** THIOTEPA
**Strength:** 15 mg/1.5mL
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intracavitary; Intravenous; Intravesical
**Labeler:** Sagent Pharmaceuticals
**Marketing category:** ANDA (ANDA209150)
**Pharmacologic class:** Alkylating Activity [MoA], Alkylating Drug [EPC]
GET
/api/v1/systems/ndc_fda/nodes/25021-246Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.